Skip to content

Management of female infertility due to PCOS with homoeopathic treatment versus allopathic treatment

Management of female infertility due to anovulatory polycystic ovarian syndrome with homoeopathic intervention versus standard conventional treatment –A randomized comparative study - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/05/068205
Enrollment
60
Registered
2024-05-31
Start date
Unknown
Completion date
Unknown
Last updated
2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N970- Female infertility associated withanovulation

Interventions

Intervention1: Individualized homoeopathic treatment: The patients fulfilling the inclusion criteria and giving written informed consent will be enrolled in the study. The individualized homoeopathic

Sponsors

Central Council for Research in Homoeopathy, Ministry of Ayush
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Female aged 18 to 30 years with complaints of infertility after 1year of try without use of contraception Normal semen analysis of Male partner Oligomenorrhea or amenorrhea Ultrasound findings of Polycystic ovaries with failure in ovulation Clinical evidence of hirsutism (Ferriman score 8 and above) and or acne (acne global severity scale score 1 and above)

Exclusion criteria

Exclusion criteria: All other causes of infertility (Uterine fibroid Tubal blockage endometriosis primary ovarian insufficiency adenomyosis congenital anomaly of uterus). History of diabetes mellitus Cushings disease hyperprolactinemia untreated hypo or hyperthyroidism adrenal hyperplasia and adrenal tumor ovarian tumor hyperthecosis. Lactating female. Self-reported cases with other uncontrolled systemic diseases like cardiovascular endocrinal diseases or Systemic infections or on other treatment therapies. Patient in need of medical emergency care. Patient unable to comply with regular follow-ups.

Design outcomes

Primary

MeasureTime frame
Establishment of UPT positive for pregnancy Confirmation of pregnancy by Assessment of Ultrasonography with details of pregnancy Timepoint: 6 months after enrollment

Secondary

MeasureTime frame
To compare in regularisation of menstrual cycle in both groups along with either ultrasonological improvement of PCO (ovulation) or improvement in hirsutism or acne. To compare the changes in Core FertiQoL score and Treatment FertiQoL score both homoeopathic group and conventional treatment group at monthly interval for 6 months.Timepoint: 6 months after enrollment

Countries

India

Contacts

Public ContactDr Padmalaya Rath

DR. D. P. RASTOGI CENTRAL RESEARCH INSTITUTE OF HOMOEOPATHY/ CCRH

drpadmalaya@gmail.com9811704560

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026